Banced Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,091
Closed -$264K 114
2017
Q3
$264K Hold
3,091
0.46% 96
2017
Q2
$254K Sell
3,091
-98
-3% -$8K 0.47% 94
2017
Q1
$268K Sell
3,189
-2
-0.1% -$160 0.49% 93
2016
Q4
$235K Hold
3,191
0.44% 95
2016
Q3
$256K Sell
3,191
-641
-17% -$51.3K 0.5% 90
2016
Q2
$321K Buy
3,832
+111
+3% +$8.36K 0.6% 69
2016
Q1
$268K Hold
3,721
0.47% 90
2015
Q4
$314K Sell
3,721
-111
-3% -$9.21K 0.56% 74
2015
Q3
$321K Buy
3,832
+675
+21% +$57K 0.59% 72
2015
Q2
$264K Buy
+3,157
New +$241K 0.36% 117

Other funds holding LLY

Banced Corp's LLY Position: Q4 2017 in Review

Banced Corp sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 3,091 shares — an estimated $264K sold.

Banced Corp first reported a position in LLY in Q2 2015 and held it in 10 quarters. The position peaked at $321K in Q2 2016. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Banced Corp reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
  • Banced Corp sold 3,091 Eli Lilly shares in Q4 2017, an estimated $264K.
  • Banced Corp first reported a position in Eli Lilly in Q2 2015 and held it in 10 quarters.
  • Banced Corp's Eli Lilly position peaked at $321K in Q2 2016.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Banced Corp's 13F filing for Q4 2017, filed 16 Jan 2018.